US6555692B1
(en)
*
|
1996-02-26 |
2003-04-29 |
California Institute Of Technology |
Preparation and use of bifunctional molecules having DNA sequence binding specificity
|
SE9601318D0
(sv)
*
|
1996-04-04 |
1996-04-04 |
Pharmacia Biosensor Ab |
Method for nucleic acid analysis
|
US6046004A
(en)
*
|
1997-02-27 |
2000-04-04 |
Lorne Park Research, Inc. |
Solution hybridization of nucleic acids with antisense probes having modified backbones
|
US6251591B1
(en)
*
|
1997-02-27 |
2001-06-26 |
Lorne Park Research, Inc. |
Quantitative method for detecting nucleotide concentration
|
US6485901B1
(en)
|
1997-10-27 |
2002-11-26 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to linear beacons
|
WO1999022018A2
(en)
*
|
1997-10-27 |
1999-05-06 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to pna molecular beacons
|
WO1999049293A2
(en)
|
1998-03-24 |
1999-09-30 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to detection complexes
|
US6420115B1
(en)
|
1999-12-21 |
2002-07-16 |
Ingeneus Corporation |
Cation mediated triplex hybridization assay
|
US6858390B2
(en)
|
1998-12-31 |
2005-02-22 |
Ingeneus Corporation |
Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes
|
US6403313B1
(en)
*
|
1999-12-21 |
2002-06-11 |
Ingeneus Corporation |
Fluorescent intensity assay for duplex and triplex nucleic acid hybridization solution utilizing fluorescent intercalators
|
US6656692B2
(en)
*
|
1999-12-21 |
2003-12-02 |
Ingeneus Corporation |
Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
|
US6294333B1
(en)
|
1998-12-31 |
2001-09-25 |
Ingeneus Corp. |
Fluorescent intensity assay for protein or peptide binding to nucleic acids
|
DK1471926T3
(da)
|
1999-06-01 |
2011-02-28 |
Baylor College Medicine |
Sammensætninger og fremgangsmåder til terapeutisk anvendelse af en atonal-associeret sekvens
|
US7537886B1
(en)
|
1999-06-22 |
2009-05-26 |
Life Technologies Corporation |
Primers and methods for the detection and discrimination of nucleic acids
|
US6645733B1
(en)
|
1999-06-25 |
2003-11-11 |
Ingeneus Corporation |
Fluorescent intensity method for assaying binding between proteins or peptides
|
US6830902B1
(en)
*
|
1999-07-02 |
2004-12-14 |
Invitrogen Corporation |
Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
|
WO2001038585A2
(en)
*
|
1999-11-24 |
2001-05-31 |
The Regents Of The University Of California |
Polymer arrays and methods of using labeled probe molecules to identify and quantify target molecule expression
|
US6927027B2
(en)
|
1999-12-21 |
2005-08-09 |
Ingeneus Corporation |
Nucleic acid multiplex formation
|
US20030181412A1
(en)
*
|
1999-12-21 |
2003-09-25 |
Ingeneus Corporation |
Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses
|
US6911536B1
(en)
|
1999-12-21 |
2005-06-28 |
Ingeneus Corporation |
Triplex and quadruplex catalytic hybridization
|
US6924108B2
(en)
*
|
1999-12-21 |
2005-08-02 |
Ingeneus Corporation |
Nucleic acid binding enhancement by conjugation with nucleotides, nucleosides, bases and/or their analogues
|
US7309569B2
(en)
*
|
1999-12-21 |
2007-12-18 |
Ingeneus, Inc. |
Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
|
US7052844B2
(en)
*
|
1999-12-21 |
2006-05-30 |
Ingeneus, Inc. |
Purification of DS-DNA using heteropolymeric capture probes and a triplex, quadruplex or homologous duplex binding mechanism
|
US6265170B1
(en)
|
2000-01-24 |
2001-07-24 |
Ingeneus Corporation |
Homogenous assay of duplex of triplex hybridization by means of multiple measurements under varied conditions
|
US6982147B2
(en)
*
|
2000-01-24 |
2006-01-03 |
Ingeneus Corporation |
Apparatus for assaying biopolymer binding by means of multiple measurements under varied conditions
|
US6613524B1
(en)
|
2000-01-24 |
2003-09-02 |
Ingeneus Corporation |
Amperometric affinity assay and electrically stimulated complexes of nucleic acids
|
US7220541B2
(en)
|
2000-01-24 |
2007-05-22 |
Ingeneus, Inc. |
Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions
|
US20030170659A1
(en)
*
|
2000-01-24 |
2003-09-11 |
Ingeneus Corporation |
Electrical treatment of binding media to encourage, discourage and/or study biopolymer binding
|
US6936443B2
(en)
*
|
2000-04-03 |
2005-08-30 |
Cytyc Corporation |
Detection and typing of human papillomavirus using PNA probes
|
EP1294939B1
(en)
*
|
2000-04-03 |
2010-01-27 |
Cytyc Corporation |
Detection and typing of human papillomavirus using pna probes
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
US20030165859A1
(en)
|
2001-10-23 |
2003-09-04 |
Invitrogen Corporation |
Primers and methods for the detection and discrimination of nucleic acids
|
DE10155031A1
(de)
*
|
2001-11-09 |
2003-05-28 |
Friz Biochem Gmbh |
Fluoreszenz-Quenchen zur Detektion von Ligat-Ligand Assoziationsereignissen in elektrischen Feldern
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
EP2221377B2
(en)
|
2002-02-01 |
2017-05-17 |
Life Technologies Corporation |
Oligonucleotide compositions with enhanced efficiency
|
WO2003064621A2
(en)
|
2002-02-01 |
2003-08-07 |
Ambion, Inc. |
HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
|
US6818420B2
(en)
|
2002-02-27 |
2004-11-16 |
Biosource International, Inc. |
Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
|
JP4796299B2
(ja)
|
2002-08-12 |
2011-10-19 |
ジェンネレックス インコーポレイティッド |
ポックスウイルスおよび癌に関する方法および組成物
|
US20040180345A1
(en)
*
|
2003-03-14 |
2004-09-16 |
Ingeneus Corporation |
Pre-incubation method to improve signal/noise ratio of nucleic acid assays
|
DE602005021525D1
(de)
|
2004-09-14 |
2010-07-08 |
Univ Colorado |
R behandlung mit bucindolol
|
CN101031659A
(zh)
*
|
2004-09-24 |
2007-09-05 |
英詹尼斯公司 |
基因组分析
|
JP2006254784A
(ja)
*
|
2005-03-17 |
2006-09-28 |
Institute Of Physical & Chemical Research |
プライマーダイマーからの非特異的増幅を減少させる方法
|
KR101772375B1
(ko)
|
2005-09-07 |
2017-08-29 |
신라젠(주) |
Gm-csf를 발현하는 폭스바이러스를 사용한 전이성 및/또는 전신 파종성 암의 전신 치료법
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
ATE378427T1
(de)
*
|
2005-10-17 |
2007-11-15 |
Rina Netzwerk Rna Technologien |
Verfahren zur bestimmung einer unbekannten pns seqenz und seine verwendungen
|
JP5606067B2
(ja)
|
2006-09-15 |
2014-10-15 |
オタワ ホスピタル リサーチ インスティテュート |
腫瘍崩壊性ラブドウイルス
|
WO2010111656A2
(en)
*
|
2009-03-27 |
2010-09-30 |
Life Technologies Corporation |
Systems and methods for assessing images
|
JP5785942B2
(ja)
|
2009-06-29 |
2015-09-30 |
ルミネックス コーポレーション |
ヘアピンコンフォメーションを有するキメラプライマーおよびその使用法
|
US9409983B2
(en)
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
WO2011032088A1
(en)
|
2009-09-11 |
2011-03-17 |
Arca Biopharma, Inc. |
Polymorphisms in the pde3a gene
|
DK2477499T3
(en)
|
2009-09-14 |
2018-06-06 |
Sillajen Biotherapeutics Inc |
COMBINATION CANCER THERAPY WITH ONCOLYTIC VACCINIA VIRUS
|
US9045729B2
(en)
|
2009-12-10 |
2015-06-02 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
ES2587191T3
(es)
|
2009-12-23 |
2016-10-21 |
Arca Biopharma, Inc. |
Métodos y composiciones para enfermedades y afecciones cardiovasculares
|
CN103429258B
(zh)
|
2011-01-04 |
2016-03-09 |
新罗杰公司 |
通过施用溶瘤痘苗病毒生成针对肿瘤抗原的抗体和生成肿瘤特异性补体依赖性细胞毒性
|
CA2828532A1
(en)
|
2011-02-28 |
2012-11-22 |
University Of Iowa Research Foundation |
Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender
|
WO2012120377A2
(en)
|
2011-03-08 |
2012-09-13 |
King Abdullah University Of Science And Technology |
Molecular biomarker set for early detection of ovarian cancer
|
EP2718427B1
(en)
|
2011-06-08 |
2017-01-11 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
Compositions for glioblastoma treatment
|
RU2483049C2
(ru)
*
|
2011-07-21 |
2013-05-27 |
Открытое акционерное общество "Научно-исследовательский институт полимерных материалов" |
Способ изготовления партии многошашечных зарядов твердого ракетного топлива
|
US10040853B2
(en)
|
2011-09-09 |
2018-08-07 |
Fred Hutchinson Cancer Research Center |
Methods and compositions involving NKG2D inhibitors and cancer
|
US10125373B2
(en)
|
2013-01-22 |
2018-11-13 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
US10363293B2
(en)
|
2013-02-21 |
2019-07-30 |
Turnstone Limited Partnership |
Vaccine composition
|
SG11201602540XA
(en)
|
2013-10-03 |
2016-04-28 |
Oklahoma Med Res Found |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
WO2016086227A2
(en)
|
2014-11-26 |
2016-06-02 |
The Regents Of The University Of California |
Therapeutic compositions comprising transcription factors and methods of making and using the same
|
US11046999B2
(en)
|
2015-09-16 |
2021-06-29 |
PetaOmics, Inc. |
Methods and compositions for genomic target enrichment and selective DNA sequencing
|
CN110462062A
(zh)
|
2017-01-26 |
2019-11-15 |
俄克拉荷马医学研究基金会 |
系统性红斑狼疮疾病活动性、强度和急性发作的生物标志物
|
CA3116539C
(en)
|
2018-10-18 |
2023-10-03 |
Oklahoma Medical Research Foundation |
Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
|
JP2022509018A
(ja)
|
2018-10-31 |
2022-01-20 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティー オブ アリゾナ |
放射線誘発肺障害のためのバイオマーカー及び使用方法
|